Indian drugmaker seeking Emergency Use Approval for 3-dose Covid-19 vaccine, touted as world’s 1st ‘genetically engineered plasmid DNA’ vaccine

Share it with your friends Like

Thanks! Share it with your friends!

Close

An Indian drugmaker has applied for Emergency Use Approval (EUA) for its Covid-19 vaccine, which is administered in a three-dose regimen. The firm claims the shot is the first ever plasmid DNA vaccine. In a press statement on Thursday, Indian pharmaceutical giant Zydus Cadila said it had conducted India’s largest Covid-19 vaccine trial to date when testing the effectiveness and safety of its new shot. The trial, it says, took place during the wave caused by the Delta variant. Comment: Black fungus cases surge in India, mostly in patients who recovered from coronavirus The firm stated that they had applied …read more

Source: Sott health news feed

    

  • Rating:
  • Views:85 views
  • Categories: Health